Skip to main content
NOVT
NASDAQ Manufacturing

Novanta Details Major Capital Restructuring with $613M Equity Units, $200M Buyback, and $1B Credit Facility

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Scientific Instrument Stocks · Technology
Sentiment info
Neutral
Importance info
8
Price
$139.74
Mkt Cap
$5.094B
52W Low
$98.27
52W High
$153.2
52W Position info
42% above low
Off High info
8.8% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

NOVT sits 42% above its 52-week low of $98.27.

Summary

Novanta Inc.'s annual report reveals a significant capital restructuring, including a $613.1 million equity unit issuance, a new $200 million share repurchase authorization, and an expanded $1.0 billion credit facility, alongside a strategic acquisition and ongoing restructuring efforts.


Key Events · Financing and Capital Events · NOVT

  • Significant Capital Raise via Tangible Equity Units

    Novanta issued 12.65 million tangible equity units in November 2025, generating $613.1 million in net proceeds. These units are mandatorily convertible into a minimum of 4.7 million and a maximum of 5.9 million common shares by November 2028.

  • New $200 Million Share Repurchase Program Authorized

    The Board of Directors approved a new share repurchase plan in September 2025, authorizing the repurchase of an additional $200.0 million worth of common shares. This follows the repurchase of 357,000 shares for $39.3 million under a prior plan in 2025.

  • Enhanced Credit Facilities for Financial Flexibility

    The company entered into a Fourth Amended and Restated Credit Agreement in June 2025, providing an aggregate credit facility of approximately $1.0 billion, including a $850.0 million revolving credit facility and an uncommitted $350.0 million accordion feature. An amendment in November 2025 increased the maximum consolidated leverage ratio and cash netting allowance.

  • Strategic Acquisition of Keonn Technologies

    In April 2025, Novanta acquired 100% of Keonn Technologies, S.L., a leader in RFID solutions, for a purchase price of $71.0 million (net of cash acquired), including up to $21.9 million in contingent consideration. This acquisition is included in the Medical Solutions segment.


Analysis · NOVT · Manufacturing

This 10-K filing provides comprehensive details on Novanta Inc.'s financial performance for fiscal year 2025, confirming a decline in net income and EPS, which was likely anticipated following the concurrent Q4 earnings release. However, the report highlights several critical capital and strategic initiatives. The issuance of $613.1 million in tangible equity units, convertible into up to 5.9 million shares, represents a substantial capital infusion but also potential dilution. This is balanced by the Board's approval of a new $200 million share repurchase program, signaling a commitment to shareholder returns. Furthermore, the company enhanced its financial flexibility with a $1.0 billion credit facility and an uncommitted $350 million accordion feature, alongside the strategic acquisition of Keonn Technologies for $71.0 million. These proactive capital management and growth-oriented actions are significant for the company's long-term strategy, despite the short-term earnings headwinds.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, NOVT was trading at $139.74 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $5.1B. The 52-week trading range was $98.27 to $153.20. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

NOVT - Latest Insights

NOVT
Nov 09, 2026, 5:00 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $144.00
Real-time Price: $114.88 info
Change: -$29.12 (-20%) info
Market Cap: $4.345B info
NOVT
Nov 09, 2026, 4:50 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $146.00
Real-time Price: $114.88 info
Change: -$31.12 (-21%) info
Market Cap: $4.345B info
NOVT
Nov 09, 2026, 4:45 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $146.00
Real-time Price: $114.88 info
Change: -$31.12 (-21%) info
Market Cap: $4.345B info
NOVT
Oct 02, 2026, 4:30 PM EDT
Filing Type: 8-K/A
Importance Score:
7
Price at Filing: $149.27
Real-time Price: $114.88 info
Change: -$34.39 (-23%) info
Market Cap: $4.345B info
NOVT
Aug 05, 2026, 5:00 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $158.00
Real-time Price: $114.88 info
Change: -$43.12 (-27%) info
Market Cap: $4.345B info